Active substance
Bismuth subsalicylate
- Health Canada 12
- Safety 1
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| BISMUTH CAPLETS | 02457121 | 262 MG | TABLET · ORAL | LSL MEDPLUS INC |
| BISMUTH SUBSALICYLATE CAPLETS | 02326582 | 262 MG | TABLET · ORAL | GUARDIAN DRUG COMPANY INC |
| BISMUTH SUBSALICYLATE SUSPENSION | 02313162 | 17.5 MG / ML | SUSPENSION · ORAL | GUARDIAN DRUG COMPANY INC |
| EXTRA STRENGTH BISMUTH | 02475855 | 35.2 MG / ML | SUSPENSION · ORAL | JUNO OTC INC |
| EXTRA STRENGTH BISMUTH SUBSALICYLATE SUSPENSION | 02328453 | 35 MG / ML | SUSPENSION · ORAL | GUARDIAN DRUG COMPANY INC |
| GASTROVOL LIQUID GELS | 02534436 | 262 MG | CAPSULE · ORAL | CHURCH & DWIGHT CANADA CORP |
| PEPTO BISMOL CAPLET - 262MG/CAPLET | 02177994 | 262 MG | TABLET · ORAL | PROCTER & GAMBLE INC |
| PEPTO BISMOL LIQUICAPS | 02499991 | 262 MG | CAPSULE · ORAL | PROCTER & GAMBLE INC |
| PEPTO-BISMOL | 02097079 | 17.6 MG / ML | SUSPENSION · ORAL | PROCTER & GAMBLE INC |
| PEPTO-BISMOL EXTRA | 02229668 | 35.2 MG / ML | SUSPENSION · ORAL | PROCTER & GAMBLE INC |
| PEPTO-BISMOL EXTRA CAPLET | 02530759 | 524 MG / TAB | TABLET · ORAL | PROCTER & GAMBLE INC |
| REGULAR STRENGTH BISMUTH | 02468646 | 17.5 MG / ML | SUSPENSION · ORAL | LSL MEDPLUS INC |
Safety signals and safety-related labeling changes
- US FDA 31 Mar 2025 HELIDAC — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions; Drug Interactions
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.